×

Do you want to link to this External Site and leave Amgen.com?

YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

×

Do you want to link to this External Site and leave Amgen.com?

YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

×

Do you want to link to this External Site and leave Amgen.com?

YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

×

Do you want to link to this External Site and leave Amgen.com?

YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

EFPIA Disclosures

Partnerships and Support

Amgen is committed to fully complying with the disclosure requirements of the European Federation of Pharmaceutical Industries and Associations (EFPIA) codes of practice.

Amgen EFPIA Disclosure Code Self-Certification Scheme

Methodology

The methodology Amgen used for the collection and organization of transfers of value to healthcare professionals and healthcare organizations can be found below.

Methodological Note - Last Updated Jun 1, 2016

Transfers of Value (ToV) To Healthcare Organizations (HCOs)

  • Donations
    We will disclose Donations and Grants we provide to HCOs that support science, technology, medicine, healthcare, research or education.
  • Contribution to the costs related to scientific and/or educational events
    We will disclose contributions towards the costs of events (fees, related expenses and sponsorships) provided by HCOs for healthcare professional education.
  • Fees for Service and Consultancy
    We will disclose fees and related expenses for travel and accommodation when Amgen contracts a HCO who provides consultancy services.

Transfers of Value (ToV) to Healthcare Professionals (HCPs)

  • Fees for Service and Consultancy
    We will disclose fees and related expenses for travel and accommodation when Amgen contracts a HCP who speaks on our behalf or provides consultancy services.
  • Contribution to the costs related to scientific and/or educational events
    We will disclose registration fees, travel and accommodation when Amgen sponsor (fund) individual HCPs to attend scientific and/or educational events.

Research and Development Transfers of Value (ToV)

We will make aggregate disclosure of ToV associated with the planning and conduct of i) non-clinical studies, ii) clinical trials and iii) prospective non-interventional studies.

Patient Organization Funding

We will disclose information on our work with patient associations including details of the activities and the level of funding provided. Reports on funding to Patient Organizations can be found here.

2015 Transfer of Value Reports

Amgen publishes the 2015 transfer of value reports in each country where we operate, on the respective Amgen website, or where required on national platforms by individual country industry associations. In countries where Amgen doesn't have an affiliate or website, we have published the reports below.

Country Last Updated Email Contact
Cyprus 28/6/2016 disclosure-greece@amgen.com
Estonia 28/6/2016 transparency.baltics@amgen.com
Latvia 28/6/2016 transparency.baltics@amgen.com
Lithuania 28/6/2016 transparency.baltics@amgen.com
Luxembourg 17/6/2016 transparent@amgen.com
Malta 28/6/2016 dl-trasparenza@amgen.com
Serbia 28/6/2016 ihccdisclosureinquiry@amgen.com
Ukraine (Russian) 28/6/2016 disclosureinquiry_russia_cis@amgen.com
Ukraine (English) 28/6/2016 disclosureinquiry_russia_cis@amgen.com

If you have any general queries on Amgen’s EFPIA Disclosure Program, contact ihccdisclosureinquiry@amgen.com.